Literature DB >> 29409022

Dysregulation of Kupffer Cells/Macrophages and Natural Killer T Cells in Steatohepatitis in LXRα Knockout Male Mice.

Kaori Endo-Umeda1, Hiroyuki Nakashima2, Naoki Umeda1, Shuhji Seki2, Makoto Makishima1.   

Abstract

Liver X receptor (LXR) α expression is mainly localized to metabolic tissues, such as the liver, whereas LXRβ is ubiquitously expressed. LXRα is activated by oxysterols and plays an important role in the regulation of lipid metabolism in metabolic tissues. In macrophages, LXRs stimulate reverse cholesterol transport and regulate immune responses. Although a high-cholesterol diet induces severe steatohepatitis in LXRα-knockout (KO) mice, the underlying mechanisms linking lipid metabolism and immune responses remain largely unknown. In this study, we investigated the role of LXRα in the pathogenesis of steatohepatitis by assessing the effects of a high-fat and high-cholesterol diet (HFCD) on hepatic immune cell proportion and function as well as lipid metabolism in wild-type (WT) and LXRα-KO mice. HFCD feeding induced severe steatohepatitis in LXRα-KO mice compared with WT mice. These mice had higher cholesterol levels in the plasma and the liver and dysregulated expression of LXR target and proinflammatory genes in both whole liver samples and isolated hepatic mononuclear cells. Flow cytometry showed an increase in CD68+CD11b+ Kupffer cells/macrophages and a decrease in invariant natural killer T cells in the liver of HFCD-fed LXRα-KO mice. These mice were more susceptible to lipopolysaccharide-induced liver injury and resistant to inflammatory responses against α-galactosylceramide or concanavalin-A treatment. The findings provide evidence for activation of bone marrow-derived Kupffer cells/macrophages and dysfunction of invariant natural killer T cells in LXRα-KO mouse liver. These findings indicate that LXRα regulates hepatic immune function along with lipid metabolism and protects against the pathogenesis of nonalcoholic steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29409022     DOI: 10.1210/en.2017-03141

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.

Authors:  Liqian Ma; Lawrence Wang; Adam T Nelson; Chaeyeon Han; Sisi He; Madeline A Henn; Karan Menon; Joy J Chen; Amy E Baek; Anna Vardanyan; Sayyed Hamed Shahoei; Sunghee Park; David J Shapiro; Som G Nanjappa; Erik R Nelson
Journal:  Cancer Lett       Date:  2020-08-28       Impact factor: 8.679

2.  Differential Role of Liver X Receptor (LXR) α and LXRβ in the Regulation of UDP-Glucuronosyltransferase 1A1 in Humanized UGT1 Mice.

Authors:  Eva Hansmann; Elvira Mennillo; Emiko Yoda; Mélanie Verreault; Olivier Barbier; Shujuan Chen; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2020-01-24       Impact factor: 3.922

3.  Liver X receptors regulate hepatic F4/80 + CD11b+ Kupffer cells/macrophages and innate immune responses in mice.

Authors:  Kaori Endo-Umeda; Hiroyuki Nakashima; Shihoko Komine-Aizawa; Naoki Umeda; Shuhji Seki; Makoto Makishima
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

Review 4.  Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells.

Authors:  Kaori Endo-Umeda; Makoto Makishima
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

Review 5.  Epigenetic Regulation of Kupffer Cell Function in Health and Disease.

Authors:  Hunter Bennett; Ty D Troutman; Mashito Sakai; Christopher K Glass
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

6.  Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor α Protected From Autoimmune Hepatitis.

Authors:  Bo Li; Min Lian; Yikang Li; Qiwei Qian; Jun Zhang; Qiaoyan Liu; Ruqi Tang; Xiong Ma
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

7.  Liver X receptors regulate natural killer T cell population and antitumor activity in the liver of mice.

Authors:  Kaori Endo-Umeda; Hiroyuki Nakashima; Shigeyuki Uno; Shota Toyoshima; Naoki Umeda; Shihoko Komine-Aizawa; Shuhji Seki; Makoto Makishima
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

8.  Integrative analysis reveals multiple modes of LXR transcriptional regulation in liver.

Authors:  Lara Bideyan; Wenxin Fan; Karolina Elżbieta Kaczor-Urbanowicz; Christina Priest; David Casero; Peter Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-15       Impact factor: 11.205

Review 9.  Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease.

Authors:  Tobias Puengel; Hanyang Liu; Adrien Guillot; Felix Heymann; Frank Tacke; Moritz Peiseler
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

10.  PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells.

Authors:  Francesca Virginia Bruschi; Thierry Claudel; Matteo Tardelli; Patrick Starlinger; Fabio Marra; Michael Trauner
Journal:  Hepatol Commun       Date:  2019-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.